InvestorsHub Logo
Followers 155
Posts 2673
Boards Moderated 0
Alias Born 01/29/2004

Re: None

Thursday, 02/02/2017 6:41:30 PM

Thursday, February 02, 2017 6:41:30 PM

Post# of 468745
I marvel at the complicated chartwork several posters here promote.

Fibonacci numbers. Elliot Wave theory. 200 and 50 day moving averages. Resistance and Support levels. So much more — none of which is usefully understood or applicable for me.

On my side, as a biologist, I understand equally complex intra-cellular reaction pathways of the molecules Anavex 2-73 can control as it restores normalized cell chemistry.

A good chartist could spend a few hours explaining to me the validity and usefulness of the arcane world of stock charts. At the end, I would be only confused.

Likewise, I could spend a few hours charting out (as it were) the normalized molecular pathways in the neuron that Anavex 2-73 so wonderfully restores. But unless one had an extensive background in neuron chemistry, my lessons would be equally confusing, providing no useful perspectives on the unique restorative reactions facilitated by Anavex 2-73.

Because of all of this, I presume the daily AVXL price ranges will continue to move along as they have: up some, down some, etc., with no breakouts in either direction.

As I see it, the only thing that will push a substantial price rise will be news of some sort of Biogen (or other pharmaceutical) collaboration. For those ignorant of both charting and neuron biochemistry (the vast majority of potential investors), an announcement of corporate collaboration will, finally, verify the Anavex story.

Where the share price goes after that is unknown. I’ll just sit back, and watch. I’m not interested in selling any AVXL shares at any time. I’ll just delightfully cash my quarterly dividend checks.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News